Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm
The personalised oncology paradigm remains challenging to deliver despite technological advances in genomics-based identification of actionable variants combined with the increasing focus of drug development on these specific targets. To ensure we continue to build concerted momentum to improve outc...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Cambridge University Press
2024
|
| _version_ | 1811140159913066496 |
|---|---|
| author | Lajmi, N Alves-Vasconcelos, S Tsiachristas, A Haworth, A Woods, K Crichton, C Noble, T Salih, H Várnai, KA Branford-White, H Orrell, L Osman, A Bradley, KM Bonney, L McGowan, DR Davies, J Prime, MS Hassan, AB |
| author_facet | Lajmi, N Alves-Vasconcelos, S Tsiachristas, A Haworth, A Woods, K Crichton, C Noble, T Salih, H Várnai, KA Branford-White, H Orrell, L Osman, A Bradley, KM Bonney, L McGowan, DR Davies, J Prime, MS Hassan, AB |
| author_sort | Lajmi, N |
| collection | OXFORD |
| description | The personalised oncology paradigm remains challenging to deliver despite technological advances in genomics-based identification of actionable variants combined with the increasing focus of drug development on these specific targets. To ensure we continue to build concerted momentum to improve outcomes across all cancer types, financial, technological and operational barriers need to be addressed. For example, complete integration and certification of the ‘molecular tumour board’ into ‘standard of care’ ensures a unified clinical decision pathway that both counteracts fragmentation and is the cornerstone of evidence-based delivery inside and outside of a research setting. Generally, integrated delivery has been restricted to specific (common) cancer types either within major cancer centres or small regional networks. Here, we focus on solutions in real-world integration of genomics, pathology, surgery, oncological treatments, data from clinical source systems and analysis of whole-body imaging as digital data that can facilitate cost-effectiveness analysis, clinical trial recruitment, and outcome assessment. This urgent imperative for cancer also extends across the early diagnosis and adjuvant treatment interventions, individualised cancer vaccines, immune cell therapies, personalised synthetic lethal therapeutics and cancer screening and prevention. Oncology care systems worldwide require proactive step-changes in solutions that include inter-operative digital working that can solve patient centred challenges to ensure inclusive, quality, sustainable, fair and cost-effective adoption and efficient delivery. Here we highlight workforce, technical, clinical, regulatory and economic challenges that prevent the implementation of precision oncology at scale, and offer a systematic roadmap of integrated solutions for standard of care based on minimal essential digital tools. These include unified decision support tools, quality control, data flows within an ethical and legal data framework, training and certification, monitoring and feedback. Bridging the technical, operational, regulatory and economic gaps demands the joint actions from public and industry stakeholders across national and global boundaries. |
| first_indexed | 2024-09-25T04:17:33Z |
| format | Journal article |
| id | oxford-uuid:a3b1a967-e99e-41ca-b388-edd7ea390118 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:17:33Z |
| publishDate | 2024 |
| publisher | Cambridge University Press |
| record_format | dspace |
| spelling | oxford-uuid:a3b1a967-e99e-41ca-b388-edd7ea3901182024-07-20T15:16:02ZChallenges and solutions to system-wide use of precision oncology as the standard of care paradigmJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a3b1a967-e99e-41ca-b388-edd7ea390118EnglishSymplectic ElementsCambridge University Press2024Lajmi, NAlves-Vasconcelos, STsiachristas, AHaworth, AWoods, KCrichton, CNoble, TSalih, HVárnai, KABranford-White, HOrrell, LOsman, ABradley, KMBonney, LMcGowan, DRDavies, JPrime, MSHassan, ABThe personalised oncology paradigm remains challenging to deliver despite technological advances in genomics-based identification of actionable variants combined with the increasing focus of drug development on these specific targets. To ensure we continue to build concerted momentum to improve outcomes across all cancer types, financial, technological and operational barriers need to be addressed. For example, complete integration and certification of the ‘molecular tumour board’ into ‘standard of care’ ensures a unified clinical decision pathway that both counteracts fragmentation and is the cornerstone of evidence-based delivery inside and outside of a research setting. Generally, integrated delivery has been restricted to specific (common) cancer types either within major cancer centres or small regional networks. Here, we focus on solutions in real-world integration of genomics, pathology, surgery, oncological treatments, data from clinical source systems and analysis of whole-body imaging as digital data that can facilitate cost-effectiveness analysis, clinical trial recruitment, and outcome assessment. This urgent imperative for cancer also extends across the early diagnosis and adjuvant treatment interventions, individualised cancer vaccines, immune cell therapies, personalised synthetic lethal therapeutics and cancer screening and prevention. Oncology care systems worldwide require proactive step-changes in solutions that include inter-operative digital working that can solve patient centred challenges to ensure inclusive, quality, sustainable, fair and cost-effective adoption and efficient delivery. Here we highlight workforce, technical, clinical, regulatory and economic challenges that prevent the implementation of precision oncology at scale, and offer a systematic roadmap of integrated solutions for standard of care based on minimal essential digital tools. These include unified decision support tools, quality control, data flows within an ethical and legal data framework, training and certification, monitoring and feedback. Bridging the technical, operational, regulatory and economic gaps demands the joint actions from public and industry stakeholders across national and global boundaries. |
| spellingShingle | Lajmi, N Alves-Vasconcelos, S Tsiachristas, A Haworth, A Woods, K Crichton, C Noble, T Salih, H Várnai, KA Branford-White, H Orrell, L Osman, A Bradley, KM Bonney, L McGowan, DR Davies, J Prime, MS Hassan, AB Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm |
| title | Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm |
| title_full | Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm |
| title_fullStr | Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm |
| title_full_unstemmed | Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm |
| title_short | Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm |
| title_sort | challenges and solutions to system wide use of precision oncology as the standard of care paradigm |
| work_keys_str_mv | AT lajmin challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT alvesvasconceloss challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT tsiachristasa challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT hawortha challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT woodsk challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT crichtonc challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT noblet challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT salihh challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT varnaika challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT branfordwhiteh challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT orrelll challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT osmana challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT bradleykm challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT bonneyl challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT mcgowandr challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT daviesj challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT primems challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm AT hassanab challengesandsolutionstosystemwideuseofprecisiononcologyasthestandardofcareparadigm |